Brand-name GLP-1s with a separate membership and insurance help
Released: · Last reviewed:
As of October 15, 2026, we could not read Ro's own pages (ro.co returned a bot challenge twice), so this review shows no current price; search summaries of its pages and our July review describe brand-name GLP-1s such as Wegovy, Zepbound, the Wegovy pill and Foundayo, with a separate membership and insurance help.
Search summaries of Ro pages mention a $39 first month and a $74 to $149 monthly membership with medication billed separately; we have not confirmed these on Ro's own pages.
| Product | Price shown | Basis / conditions | Source | Read |
|---|---|---|---|---|
| Membership | not re-read | ro.co returned a 403 bot challenge twice on October 15 | ro.co | Oct 15, 2026 |
| Medication | not re-read | July review: brand-name drugs billed separately (not re-verified) | ro.co | Oct 15, 2026 |
Self-pay brand prices are set by the manufacturers: Zepbound through LillyDirect is $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg with refills within 45 days; the Wegovy pen through NovoCare is $349 and the Wegovy pill $149 to $299. Any Ro membership is added to those figures. If you have Medicare Part D and qualify, the CMS GLP-1 Bridge copay is $50 a month through 2027.
People who want FDA-approved brand-name medication and help with insurance, and who accept a membership fee on top.
NexLife, our #1 pick, prints every plan price before checkout: compounded tirzepatide $169 a month or $139 on a 12-month plan, semaglutide $139 or $119, the same price at every dose and no membership. A year on its 12-month tirzepatide plan is $1,668. Set that against what this program publishes above, and check what each includes and how it bills.
Award on our homepage: Best for brand-name GLP-1s with insurance help. Score: July 2026 score (earlier rubric); v4.1 re-score pending.
Related: October 2026 price index · how programs screen patients · how we rank · all reviews